期刊文献+

全程护理干预围手术期肺癌患者的临床观察 被引量:1

Clinical Observation of Whole Course Nursing Intervention in Perioperative Lung Cancer Patients
下载PDF
导出
摘要 目的探讨对肺癌围手术期患者应用全程护理干预的临床效果。方法取自2016年1月至2017年1月我大连大学新华医院手术室接受肺癌手术的患者60例,随机分为对照组30例,采用常规护理方法,试验组30例,在对照组的基础上采用全程护理干预的护理方法,观察两组患者的不良反应发生率和感染发生率。结果试验组优于对照组,有统计学差异(P<0.05)。结论全程护理干预围手术期肺癌患者,可以减轻患者的不良反应发生率,降低患者感染率,值得推广应用。 Objective To investigate the effect of whole course nursing intervention on patients with lung cancer during perioperative period. Methods 60 patients from January 2016 to January 2017 I Dalian University of Xinhua Hospital operation room lung cancer surgery, were randomly divided into control group 30 cases, using conventional methods of nursing, 30 cases of test group and nursing methods of nursing intervention on the basis of the control group, observe two groups of patients with adverse reaction incidence and infection rate. Results The experimental group was better than the control group, there was significant difference(P〈0.05). Conclusion The whole process of nursing intervention for patients with lung cancer in perioperative period can reduce the incidence of adverse reactions and reduce the infection rate, which is worthy of popularization and application.
作者 乔玉萍 曲凤 杜洋 徐浩鑫 QIAO Yu-ping, QU Feng, DU Yang, XU Hao-xin(1. Department of lnfectious Diseases, Xinhua Hospital Affiliated to Dalian University Dalian 116000, China, 2 Department of Surgery, Xinhua Hospital Affiliated to Dalian University, Dalian 116000, Chin)
出处 《中国医药指南》 2018年第18期16-17,共2页 Guide of China Medicine
关键词 肺癌 全程护理 不良反应发生率 感染率 Lung cancer Whole course nursing Adverse reaction rate Infection rate
  • 相关文献

参考文献5

二级参考文献22

  • 1程炎芳.肺癌患者的护理[J].临床肺科杂志,2005,10(3):308-308. 被引量:4
  • 2程剑.肺癌围手术期的护理[J].医疗装备,2005,18(9):44-45. 被引量:7
  • 3陈德凤,郎红娟,杨洁凌,杨春香.开胸手术术前肺功能锻炼的护理指导[J].解放军护理杂志,2006,23(4):14-15. 被引量:24
  • 4李秀娥,张继芝,柴秀萍.全肺切除患者围手术期护理[J].齐鲁护理杂志,2007,13(2):27-28. 被引量:20
  • 5吴清美.肺癌患者围手术期护理体会[J].现代中西医结合杂志,2007,16(25):3728-3729. 被引量:1
  • 6Stewart J S, Cohen E E, Licilra L, et al. Phase Ⅲ sludy of ge fitinib compared with intravenous metholrexate for recurrent squa mous cell carcinoma of the head and neckEcorrected[J]. J Clin Oncol, 2009,27: 1864- 1871.
  • 7Izzedine H, Ederhy S, Goldwasser F, et al. Management of hyper- tension in angiogenesisinhibitor treated patients[J]. Ann Oncol, 2009,20:807-815.
  • 8Llovet J M, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatoeellular carcinorna[J]. N Engl J Med,2008,359:378-390.
  • 9Chen H X, Cleck J N. Adverse effects of antfcancer agents that target the VEGF pathway[J]. Nat Rev Clin Oncol,2009,8:465-477.
  • 10Rini B I, Tamaskar I. Shaheen P, et al. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib[J]. J NatlCancer Inst,2007,99:81-83.

共引文献29

同被引文献7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部